Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany

Bibliographic Details
Main Authors: Liedgens, H, Hertel, N, Gabriel, A, Nuijten, M, Dakin, H, Sphrer, U, Poulsen Nautrup, B
Format: Journal article
Published: 2007
_version_ 1797103114182983680
author Liedgens, H
Hertel, N
Gabriel, A
Nuijten, M
Dakin, H
Sphrer, U
Poulsen Nautrup, B
author_facet Liedgens, H
Hertel, N
Gabriel, A
Nuijten, M
Dakin, H
Sphrer, U
Poulsen Nautrup, B
author_sort Liedgens, H
collection OXFORD
description
first_indexed 2024-03-07T06:15:29Z
format Journal article
id oxford-uuid:f0f1eab9-4609-4862-b04d-93f9acd37469
institution University of Oxford
last_indexed 2024-03-07T06:15:29Z
publishDate 2007
record_format dspace
spelling oxford-uuid:f0f1eab9-4609-4862-b04d-93f9acd374692022-03-27T11:52:02ZCostutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in GermanyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f0f1eab9-4609-4862-b04d-93f9acd37469Symplectic Elements at Oxford2007Liedgens, HHertel, NGabriel, ANuijten, MDakin, HSphrer, UPoulsen Nautrup, B
spellingShingle Liedgens, H
Hertel, N
Gabriel, A
Nuijten, M
Dakin, H
Sphrer, U
Poulsen Nautrup, B
Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany
title Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany
title_full Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany
title_fullStr Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany
title_full_unstemmed Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany
title_short Costutility analysis evaluating the lidocaine 5% medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in Germany
title_sort costutility analysis evaluating the lidocaine 5 medicated plaster relative to gabapentin and pregabalin for postherpetic neuralgia in germany
work_keys_str_mv AT liedgensh costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany
AT herteln costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany
AT gabriela costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany
AT nuijtenm costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany
AT dakinh costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany
AT sphreru costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany
AT poulsennautrupb costutilityanalysisevaluatingthelidocaine5medicatedplasterrelativetogabapentinandpregabalinforpostherpeticneuralgiaingermany